AMRS - アミリス (Amyris Inc.)


   NRG among Energy/Material gainers; Clean Energy Fuels and Amyris among losers  2022/05/06 18:13:28 Seeking Alpha
Gainers: Mesa Royalty (MTR) +21%. DMC Global (BOOM) +18%
EMERYVILLE, Calif., May 3, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world''s transition to sustainable consumption through its Lab-to-Market™ technology platform, today announced that it will issue its financial results…
   Amryis Update: Building Value One Brick At A Time  2022/04/28 21:04:07 Seeking Alpha
Amyris is the leading Synthetic Bio company with significant and growing revenues & a flywheel of opportunities to come. Find out why I''m bullish on AMRS stock.
   Amyris Inc. (NASDAQ: AMRS) Stock Dropped -4.60% Over A Month – Are There Any Chances Of Growth?  2022/04/21 14:00:00 Marketing Sentinel
During the last session, Amyris Inc. (NASDAQ:AMRS)’s traded shares were 3.27 million, with the beta value of the company hitting 1.56. At the end of the trading day, the stock’s price was $4.15, reflecting an intraday loss of -3.04% or -$0.13. The 52-week high for the AMRS share is $17.42, that puts it down -319.76 … Amyris Inc. (NASDAQ: AMRS) Stock Dropped -4.60% Over A Month – Are There Any Chances Of Growth? Read More »
   Amyris Inc.’s Stock Gains 2.82%, But It May Still Be Worth Investing In.  2022/04/19 18:00:00 Stocks Register
The trading price of Amyris Inc. (NASDAQ:AMRS) floating higher at last check on Tuesday, April 19, closing at $4.37, 2.82% higher than its previous close. >> 5 Best Growth Stocks for 2022 << >> 5 Best Growth Stocks for 2022 << Traders who pay close attention to intraday price movement should know that it has … Amyris Inc.’s Stock Gains 2.82%, But It May Still Be Worth Investing In. Read More »
   AMRS Stock: Why Biotech Stock Amyris Is Shooting Higher Today  2021/07/19 19:52:23 InvestorPlace
Shares of AMRS stock are on the move today as retail investors appear to be intrigued by this name, providing buying momentum.
   Zymergen, Amyris lead energy gainers; MV Oil Trust, Summit Midstream among major losers  2021/07/19 18:01:24 Seeking Alpha
   Global Synthetic Biology Market Size by Leading Industry Players 2021 Amyris, DuPont, GenScript USA, Intrexon, Integrated DNA Technologies, New England Biolabs  2021/07/15 11:25:33 OpenPR
The Global Synthetic Biology Market Report recently published by The Research Corporation is a professional and in-depth study on the current state of the industry. Different exploratory techniques such as, qualitative and quantitative analysis have been used to give data
   Industry Executive Says Synthetic Biology Is the Next Silicon Valley  2021/07/07 20:49:41 GuruFocus
Leaders include Amyris, Precigen and Twist Bioscience Related Stocks: AMRS , PGEN , TWST , ILMN , MSFT , SRNG , WDC , CDXS ,
   Amyris inks exclusive license agreement for RNA COVID vaccine development  2021/07/01 12:35:53 Seeking Alpha
   Jon Najarian Sees Unusual Option Activity In Peloton And Amyris  2021/04/08 16:46:09 Benzinga
On CNBC's "Fast Money Halftime Report," Jon Najarian gave some unusual option activity plays. Najarian sees unusual activity in: Peloton … Full story available on
   Here Are Top 5 Stocks Analysts Betting on Right Now  2021/03/22 09:26:18 Coinspeaker
These are the top 5 stocks with Buy ratings from Wall Street analysts: Microsoft, Amazon, Amyris, Addus Homecare and Alphatec.
   3 Monster Growth Stocks That Score A ‘Perfect 10’ | UK  2021/03/18 07:41:06 UK
Shares Analysis by Investing Insights covering: Amyris Inc, Clean Energy Fuels Corp, Waste Connections Inc, Aemetis Inc. Read Investing Insights 's latest article on UK.
   Amyris Enters Partnership With Minerva Foods For Zero Carbon Protein Production  2021/03/16 12:00:00 PR Newswire
EMERYVILLE, Calif., March 16, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, announced today that it has signed…
   Amyris (NASDAQ:AMRS) Releases Earnings Results, Misses Expectations By $0.33 EPS  2021/03/03 19:38:42 Transcript Daily
Amyris (NASDAQ:AMRS) issued its quarterly earnings results on Monday. The biotechnology company reported ($0.44) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.11) by ($0.33), MarketWatch Earnings reports. Shares of NASDAQ AMRS traded down $1.70 during trading on Wednesday, reaching $18.25. The stock had a trading volume of 161,774 shares, compared […]